Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue Article

Hunter, SB, Abbott, K, Varma, VA et al. (1995). Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue . JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 54(1), 57-64. 10.1097/00005072-199501000-00007

cited authors

  • Hunter, SB; Abbott, K; Varma, VA; Olson, JJ; Barnett, DW; James, CD

authors

abstract

  • A series of 43 human gliomas, consisting of 30 glioblastomas, 7 anaplastic astrocytomas, 3 low grade astrocytomas, 2 ependymomas, and I oligodendroglioma, was studied for amplification of the epidermal growth factor receptor (EGFR) and mouse double minute 2 (MDM2) genes. DNA extracted from formalin-fixed, paraffin-embedded tissue sections was analyzed by differential PCR and the results were compared with slot blot examination of DNA extracted from frozen tissue from the same neoplasms. Twelve glioblastomas (40%) showed amplification of the EGFR gene, and overexpression of EGFR was evident in each of these tumors as indicated by the immunoperoxidase technique. Two of the tumors with EGFR gene amplification also revealed amplification of the MDM2 gene, while one additional glioblastoma revealed MDM2 amplification only. A 100% concordance in the detection of amplification was observed between differential PCR and slot blot analysis; consequently, these results indicate that differential PCR using DNA extracted from archival tissue sections is a reliable method or demonstrating gene amplifications in glial tumors. © 1995 by the American Association of Neuropathologists.

publication date

  • January 1, 1995

published in

Digital Object Identifier (DOI)

start page

  • 57

end page

  • 64

volume

  • 54

issue

  • 1